BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $528,000 | +15.5% | 156,558 | 0.0% | 0.00% | – |
| Q4 2018 | $457,000 | -76.4% | 156,558 | -50.1% | 0.00% | -100.0% |
| Q3 2018 | $1,934,000 | +56.7% | 313,820 | +87.6% | 0.00% | 0.0% |
| Q2 2018 | $1,234,000 | +23.2% | 167,260 | +9.6% | 0.00% | 0.0% |
| Q1 2018 | $1,002,000 | -7.6% | 152,668 | +18.5% | 0.00% | 0.0% |
| Q4 2017 | $1,084,000 | -24.8% | 128,846 | +3.2% | 0.00% | 0.0% |
| Q3 2017 | $1,442,000 | +15.2% | 124,852 | +16.5% | 0.00% | 0.0% |
| Q2 2017 | $1,252,000 | +76.1% | 107,154 | +86.1% | 0.00% | 0.0% |
| Q1 2017 | $711,000 | -12.3% | 57,583 | -3.2% | 0.00% | 0.0% |
| Q4 2016 | $811,000 | -38.4% | 59,517 | -10.1% | 0.00% | 0.0% |
| Q3 2016 | $1,317,000 | +53.7% | 66,176 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $857,000 | +232.2% | 66,140 | +139.5% | 0.00% | – |
| Q1 2016 | $258,000 | -53.9% | 27,620 | 0.0% | 0.00% | – |
| Q4 2015 | $560,000 | +39.7% | 27,620 | 0.0% | 0.00% | – |
| Q3 2015 | $401,000 | -31.7% | 27,620 | 0.0% | 0.00% | – |
| Q2 2015 | $587,000 | +52.5% | 27,620 | +66.1% | 0.00% | – |
| Q1 2015 | $385,000 | – | 16,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |